Abbott announces the U.S. launch of the IonicRF Generator for use in patients living with chronic pain.

Abbott announced the launch of the IonicRF Generator – a new device recently cleared by the FDA to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain. The new device is the first Abbott-developed radiofrequency ablation device and is currently approved in the United States and Europe. "Every patient is different and the source of their pain is unique, making it extremely important to have multiple options available, so treatment can be tailored to individual circumstances," said Jason E. Pope, M.D., Evolve Restorative Center, Santa Rosa, Calif. "Abbott's IonicRF is an advanced device platform that targets specific nerves to block pain signals from reaching the brain. One of the most promising aspects of the therapy is its effectiveness in targeting pain in several discrete areas of the body..